A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Recruiting

Early Phase 1

NiacinamideA Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Sponsor:

Marissa Lobl

Code:

NCT07286318

Conditions

Skin Cancer

Cutaneous Squamous Cell Carcinoma (CSCC)

Actinic Keratosis (AK)

Organ Transplant Recipient

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Topical niacinamide 5% cream

Sunscreen

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-24. This information was provided to ClinicalTrials.gov by Marissa Lobl on 2026-06-05.